
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year |
Award Type![]() |
Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2020 | R44 | CA250672 | PAR-18-303 | WINTERS, IAN PAUL | D2G ONCOLOGY, INC. | Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform | Active |
2000 | R44 | CA081954 | PAR-98-066 | LIFSHITZ, NADIA | BIOPHOTONICS CORPORATION | HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING | Complete |
2002 | R44 | CA088396 | PAR-01-105 | MOEN, PHILLIP T | ONE CELL SYSTEMS, INC | DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS | Complete |
2000 | R44 | CA082038 | PAR-98-066 | ANDERSON, N LEIGH | LARGE SCALE BIOLOGY CORPORATION | PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH | Complete |
1999 | R44 | CA081954 | PAR-98-066 | LIFSHITZ, NADIA | BIOPHOTONICS CORPORATION | HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING | Complete |
1999 | R44 | CA082038 | PAR-98-066 | ANDERSON, N LEIGH | LARGE SCALE BIOLOGY CORPORATION | PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH | Complete |
2005 | R44 | CA101106 | RFA-CA-05-006 | RUSH, JOHN | CELL SIGNALING TECHNOLOGY, INC. | IMMUNOAFFINITY ISOLATION OF PHOSPHOPEPTIDES | Complete |
2005 | R44 | CA107988 | PAR-01-105 | BALGLEY, BRIAN M. | CALIBRANT BIOSYSTEMS, INC. | INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS | Complete |
2008 | R44 | CA134258 | RFA-CA-07-039 | GUO, BAOCHUAN | GLC BIOTECHNOLOGY, INC. | MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY | Complete |
2008 | R44 | CA134310 | RFA-CA-07-041 | LEE, BRIAN W | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO | Complete |
2006 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA114126 | RFA-CA-07-039 | LIM, MARK | AMBERGEN, INC | ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE | Complete |
2006 | R44 | CA097569 | RFA-CA-06-005 | BRADY, ERIK D | MICROCOSM, INC. | ENHANCED CANCER MICROARRAY | Complete |
2006 | R44 | CA121155 | RFA-CA-06-005 | LU, PETER S. | ARBOR VITA CORPORATION | A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES | Complete |
2020 | R44 | CA247353 | PAR-18-303 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC. | Spatial and single cell analysis of tumor microenvironment by seqFISH+ | Active |
2008 | R44 | CA120619 | RFA-CA-07-041 | LEE, PHILIP J | CELLASIC CORPORATION | MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS | Complete |
2008 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA128858 | RFA-CA-07-008 | DOLINGER, DAVID LEE | IQUUM, INC. | RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS | Complete |
2021 | R44 | CA261523 | PAR-18-303 | HUNG, PAUL JU-SUNG | COMBINATI, INC. | Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring | Active |
2016 | R44 | CA199194 | PAR-13-327 | KARSTEN, STANISLAV | NEUROINDX INC. | Automated Platform for Fixed Tissue Microdissection | Complete |
2006 | U43 | CA122745 | RFA-CA-06-006 | BALGLEY, BRIAN M. | CALIBRANT BIOSYSTEMS, INC. | BREAST CANCER PROTEOMIC VIA LASER-FREE MICRODISSECTION AND GEMINI TECHNOLOGIES | Complete |